Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced an expanded partnership with SHL Telemedicine (NASDAQ: SHLT) to integrate the SmartHeart® portable 12-lead ECG device across DocGo mobile health care units. This expanded collaboration, initially launched in the New York-New Jersey area, will now bring advanced cardiovascular diagnostics to patients' homes and underserved communities i.» Mehr auf businesswire.com
SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity
TEL AVIV & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has clarified today that it is in discussions with Discount Capital Ltd. the investment arm of Israel Discount Bank, regarding a possible investment relating to SHL's Israeli activity. At this point, the parties have not yet taken any decision nor entered into any binding obligation with regard to.» Mehr auf businesswire.com
SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is proud to announce that it has expanded its offering in Israel to include the groundbreaking ability to perform at-home Biomarker blood tests. This diagnostic tool is designed to rapidly identify cardiac markers for detection of a heart attack, transforming emergency cardiac care with sp.» Mehr auf businesswire.com
Unternehmenszahlen
(EUR) | Juni 2024 | |
---|---|---|
Umsatz | 12,98 Mio | - |
Bruttoeinkommen | 6,10 Mio | - |
Nettoeinkommen | −1,86 Mio | - |
EBITDA | −96,41k | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 28,53 Mio€ |
Anzahl Aktien | 16,39 Mio |
52 Wochen-Hoch/Tief | 5,08€ - 1,57€ |
Dividenden | Nein |
Beta | 0,29 |
KGV (PE Ratio) | −8,54 |
KGWV (PEG Ratio) | −2,82 |
KBV (PB Ratio) | 0,51 |
KUV (PS Ratio) | 1,21 |
Unternehmensprofil
Name | SHL TELEMEDICINE SP. ADR |
CEO | David Arnon |
Mitarbeiter | 583 |
Ticker Symbole
Börse | Symbol |
---|---|
NASDAQ | SHLT |
Assets entdecken
Shareholder von SHL TELEMEDICINE SP. ADR investieren auch in folgende Assets